PMAM
KITE

Picton Mahoney Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Picton Mahoney Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,700
Closed -$135K – 365
2016
Q2 		$135K Buy
+2,700
New +$133K 0.01% 223

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Picton Mahoney Asset Management's KITE Position: Q3 2016 in Review

Picton Mahoney Asset Management sold out of Kite Pharma, Inc. (KITE) in Q3 2016, closing a stake of 2,700 shares — an estimated $135K sold.

Picton Mahoney Asset Management first reported a position in KITE in Q2 2016 and held it in 1 quarter. The position peaked at $135K in Q2 2016. 195 funds tracked by Wall St. Rank hold KITE as of Q3 2016.

  • Picton Mahoney Asset Management reported no remaining Kite Pharma, Inc. position as of Q3 2016 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 2,700 Kite Pharma, Inc. shares in Q3 2016, an estimated $135K.
  • Picton Mahoney Asset Management first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Kite Pharma, Inc. position peaked at $135K in Q2 2016.
  • 195 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2016.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.